Topic:
M&A
Latest Headlines
Latest Headlines
Quest buys Humana's lab business, inks testing deal
Quest Diagnostics is on a buying spree to grow its testing business, and now the company has signed a deal to buy the toxicology and clinical laboratory segment of health insurance giant Humana.
WSJ: Novartis said to eye $16B offer for Actavis
Actavis has suddenly become the belle of the ball. The Wall Street Journal reports that Novartis is now entertaining a $16 billion bid for the generics maker after a $13 billion offer from Valeant and a $15 billion bid from Mylan both fell flat.
Actavis nixed a $15B offer from Mylan to zero in on Warner Chilcott
We thought Actavis had a love triangle going with potential merger partners Warner Chilcott and Valeant Pharmaceuticals, as an analyst dubbed it earlier this week. Now, news emerges that it's more like a love quadrangle, with rejections on two sides.
AstraZeneca, Astellas among Optimer bidders, Bloomberg sources say
Who wants Optimer Pharmaceuticals and its high-powered antibiotics? A handful of drugmakers, apparently.
HemCon, a struggling wound dressing device maker, is sold
A year after HemCon Medical Technologies filed for Chapter 11 reorganization following the loss of a patent fight, the Oregon maker of gels and dressings has been sold.
Theragenics weighs buyout offer worth up to $71.4M
As its net profits careen into the red, Theragenics is considering a buyout offer worth up to $71.4 million from private equity outfit Juniper.
Actavis, Warner in buyout talks potentially worth $5B-plus
While Valeant Pharmaceuticals was chatting up Actavis about a potential merger-of-equals, Actavis was apparently mulling a bid for Warner Chilcott, the Irish drugmaker that specializes in women's health and dermatology.
IT outfit Instem acquires Logos to penetrate early clinical trials market
Instem has bought a ticket to play a larger role in the market for early-stage clinical trials. The provider of IT solutions has acquired Logos Technologies, which provides electronic data-capture (EDC) software for pharma, biotech and CRO companies.
Biosensors International grabs next-gen imaging company for $51M
Swiss cardiac stent maker Biosensors International will pay at least $51 million for U.S.-based Spectrum Dynamics, a developer of high-definition medical imaging technology.
AbbVie, Pfizer's Zoetis deals ignite enormous leap in M&A value
Pfizer's spinoff of its animal health business into Zoetis is the biggest IPO this year. And the spinoff that created the newest Big Pharma company, AbbVie, was no slouch.
